Risk variables of heart failure among patients in China: grey relational approach based multi-dimensional assessment

Xue Wang1, Chao Deng1, Xiantong Cao1

  • 1Department of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, P.R. China.

PubMed

Insights

Type 2 diabetes (T2DM), severe dyslipidemia, and high-grade hypertension are strongly linked to heart failure development. Understanding these key risk factors is crucial for managing cardiac diseases and improving patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Effective management of cardiac diseases relies on understanding potential risk factors.
  • This study quantifies the associations of identified risk factors with heart failure.
  • It compares the mortality associations of hypertension, uncontrolled diabetes, and uncontrolled hyperlipidemia with other factors like stroke and obesity.

Purpose of the Study:

  • To quantify the association of identified risk factors with heart failure.
  • To compare the mortality association of hypertension, uncontrolled diabetes, and uncontrolled hyperlipidemia using the Grey Relational Approach (GRA).
  • To assess the impact of stroke, lung diseases, smoking, stress, obesity, and lack of exercise on heart failure.

Main Methods:

  • Utilized data from the Global Burden of Disease (GBD) study (2001-2017).
  • Employed the Grey Relational Approach (GRA) with Grey [8.0] software for analysis.
  • Categorized GRA into Deng, absolute, and SS methods to assess variable associations.

Main Results:

  • Type 2 diabetes (T2DM) showed the strongest relationship with heart failure, increasing morbidity and mortality.
  • Severe dyslipidemia was the second highest risk factor, followed by high-grade hypertension.
  • GRA analyses indicated varying top risk factors (T2DM, dyslipidemia, hypertension) depending on the specific GRA method used.

Conclusions:

  • T2DM, severe dyslipidemia, and high-grade hypertension are strongly correlated with heart failure development.
  • These findings underscore the importance of managing these specific risk factors.
  • The study considered stroke, lung diseases, smoking, stress, obesity, and lack of exercise as additional key risk factors.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
103
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
95